Answers are grounded in this paper and cite their sources.
Surgical treatment of the axilla in patients with breast cancer has changed with the arrival of the neoadjuvant systemic therapies (NST); the role of axillary lymph node dissection with the use of radiotracers, fluorescent particles, surgical clips and radioactive seeds appears to play a significant role following these systemic therapies. We present a novel dual technique (99mTc-Nanocoll® or 99mTc-Lymphoseek®) for sentinel lymph node biopsy (SLNB) and the use of magnetic seed (Magseed®) for the achievement of more accurate and less invasive method to restaging the axilla after NST.
No takes yet. Share an insight, caveat, or question.
Gallo et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: